Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of igf-i in cultured choriocarcinoma cells

Endocrinology

Volumn 122, Issue 5, 1988, Pages 2150-2157

  Ritvos, Olli ^a   Ranta, Tapio ^a   Jalkanen, Jyrki ^a   Suikkari, Anne Maria ^a   Voutilainen, Raimo ^a,b   Bohn, Hans ^c   Rutanen, Eeva Marja ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Behringwerke AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN RECEPTOR;

AUTORADIOGRAPHY; CELL CULTURE; CHORIOCARCINOMA; CROSS LINKING; DECIDUA; HUMAN; HUMAN CELL; METHODOLOGY; PREGNANCY;

BINDING, COMPETITIVE; CARRIER PROTEINS; CELL LINE; CHORIOCARCINOMA; DECIDUA; FEMALE; HUMAN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEINS; IODINE RADIOISOTOPES; KINETICS; MOLECULAR WEIGHT; PREGNANCY; RECEPTOR, INSULIN; RECEPTORS, SOMATOMEDIN; RECOMBINANT PROTEINS; SOMATOMEDINS; SUPPORT, NON-U.S. GOV'T; UTERINE NEOPLASMS;

EID: 0023908498     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo-122-5-2150     Document Type: Article

References (52)

1. Franchimont P 1986 Paracrine control. Clin Endocrinol Metab15:1
2. D’Ercole AJ, Stiles AD, Underwood LE 1984 Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81:935
3. Baxter RC 1986 The somatomedins: insulin-like growth factors. Adv Clin Chem 25:49
4. Rechler MM, Zapf J, Nissley SP, Froesch ER, Moses AC, Pod-skalny JM, Shilling EE, Humbel RE 1980 Interactions of insulinlike growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology 107:1451
5. Wilkins JR, D’Ercole AJ 1985 Affinity-labeled plasma somatomedin C/insulin-like growth factor I binding proteins. J Clin Invest75:1350
6. Baxter RC, Martin JL, Tyler MI, Howden MEH 1986 Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins. Biochem Biophys Res Commun 139:1256
7. Koistinen R, Kalkkinen N, Huhtala M-L, Seppala M, Bohn H, Rutanen E-M 1986 Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. Endocrinology 118:1375
8. Povoa G, Enberg G, Jornvall H, Hall K 1984 Isolation and characterization of a somatomedin-binding protein from mid-term amniotic fluid. Eur J Biochem 144:199
9. Drop SLS, Kortleve DJ, Guyda HJ 1984 Isolation of a somatomedin-binding protein from preterm amniotic fluid. Developement of a radioimmunoassay. J Clin Endocrinol Metab 59:899
10. Cohen S, Taylor JM 1974 Epidermal growth factor, chemical and biological considerations. Recent Prog Horm Res 30:533
11. Lembach JL 1976 Induction of human fibroblast proliferation by epidermal growth factor (EGF): Enhancement by an EGF-binding arginine esterase and by ascorbate. Proc Natl Acad Sci USA 73:183
12. Nakamura T, Kitazawa K, Ichihara A 1986 Partial purification and characterization of masking protein for β-type transforming growth factor from rat platelets. Biochem Biophys Res Commun141:176
13. Povoa G, Roovete A, Hall K 1984 Cross reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) 107:563
14. Povoa G, Isaksson M, Jornvall H, Hall K 1985 The somatomedinbinding protein isolated from a human hepatoma cell line is identical to the amniotic fluid somatomedin-binding protein. Biochem Biophys Res Commun 128:1071
15. Chochinov RH, Mariz IK, Hajek AS, Daughaday WH 1977 Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay. J Clin Endocrinol Metab 44:902
16. Meuli C, Zapf J, Froesch ER 1978 NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart. Diabetologia 14:255
17. Drop SLS, Valiquette G, Guyda HJ, Corvol MT, Posner BI 1979Partial purification and characterization of a binding protein for insulin-like activity (NSILAs) in amniotic fluid: A possible inhibitor of insulin-like activity. Acta Endocrinol (Copenh) 90:505
18. Knauer DJ, Smith GL 1980 Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. Proc Natl Acad Sci USA 77:7252
19. Herington AC, Kuffer AD 1981 Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction. Endocrinology 109:1634
20. Bohn H, Kraus W 1980 Isolierung und Charakterisierung eines neuen plazentaspezifischen Proteins (PP12). Arch Gynecol 229:279
21. Rutanen E-M, Koistinen R, Wahlstrom T, Bohn H, Ranta T, Seppala M 1985 Synthesis of placental protein 12 by human decidua. Endocrinology 116:1304
22. Rutanen E-M, Menabawey M, Isaka K, Bohn H, Chard T, Grud-zinskas JG 1986 Synthesis of placental protein 12 by decidua from early pregnancy. J Clin Endocrinol Metab 63:675
23. Shen SJ, Wang CY, Nelson KK, Jansen M, Ilan J 1986 Expression of insulin-like growth factor II in human placentas from normal and diabetic pregnancies. Proc Natl Acad Sci USA 83:9179
24. Liu KS, Wang CY, Mills N, Gyves M, Ilan J 1985 Insulin-related genes expressed in human placenta from normal and diabetic pregnancies. Proc Natl Acad Sci USA 82:3868
25. Voutilainen R, Miller WL 1987 Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc, in human steroidogenic tissues. Proc Natl Acad Sci USA 84:1590
26. Marshall RN, Underwood LE, Voina SJ, Foushee DB, Van Wyk JJ 1974 Characterization of insulin and somatomedin-C receptors in human placental cell membranes. J Clin Endocrinol Metab39:283
27. Massague J, Czech MP 1982 The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem 257:5038
28. Fant M, Munro H, Moses AC 1986 An autocrine/paracrine role for insulin-like growth factors in the regulation of human placental growth. J Clin Endocrinol Metab 63:499
29. Ritvos O, Rutanen E-M, Pekonen F, Jalkanen J, Suikkari A-M, Ranta T 1988 Characterization of functional type I insulin-like growth factor receptors from human choriocarcinoma cells. Endocrinology 122:395
30. Peters MA, Lau EP, Snitman DL, Van Wyk JJ, Underwood LE, Russel WE, Svoboda ME 1985 Expression of a biologically active analogue of somatomedin-C/insulin-like growth factor I. Gene35:83
31. Moses AC, Nissley SP, Passamani J, White RM 1979 Further characterization of GH-dependent somatomedin-binding protein in rat serum and demonstration of somatomedin-binding protein produced by rat liver cells in culture. Endocrinology 104:536
32. De Vroede MA, Rechler MM, Nissley SP, Joshi S, Burhe GT, Katsoyannis PG 1985 Hybrid molecules containing the B-domain of insulin-like growth factor I (IGF-I) are recognized by IGF carrier proteins. Proc Natl Acad Sci USA 82:3010
33. Rutanen E-M, Bohn H, Seppala M 1982 Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease. Am J Obstet Gynecol 144:460
34. Suikkari A-M, Rutanen E-M, Seppala M 1987 Circulating levels of immunoreactive insulin-like growth factor-binding protein in non-pregnant women. Hum Reprod 2:297
35. 4. Nature 227:680
36. Voutilainen R, Tapanainen J, Chung B, Matteson KJ, Miller WL1986 Hormonal regulation of P450scc (20,22 desmolase) and P450cl7 (17 a-hydroxylase/17,20 lyase) in cultured human granulosa cells. J Clin Endocrinol Metab 63:202
37. Bell GI, Merryweather JP, Sanchez-Pescador R, Stempien MM, Priestly L, Scott J, Rail LB 1984 Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature310:775
38. 125iodine. Anal Biochem 67:1
39. 3 rat pituitary cells: messenger ribonucleic acid content, immunocytochemistry, and secretion. Endocrinology 120:2037
40. Koistinen R, Huhtala M-L, Stenman U-H, Seppala M 1987 Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding properties. Clin Chim Acta164:293
41. Baxter RC, Martin JL, Wood MH 1987 Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. J Clin Endocrinol Metab65:423
42. Kohler PO, Bridson WE, Hammond JM, Weintraub B, Kirschner MA, Van Thiel DH 1971 Clonal lines of human choriocarcinoma cells in culture. Acta Endocrinol (Copenh) [Suppl]153:137
43. Grizzard JD, D’Ercole AJ, Wilkins JR, Moats-Staats BM, Williams RW 1984 Affinity-labeled somatomedin C receptors and binding proteins from the human fetus. J Clin Endocrinol Metab 58:535
44. Rutanen E-M, Pekonen F, Makinen T 1988 Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: Evidence for autocrine/paracrine control of growth factor action. J Clin Endocrinol Metab 66:173
45. Clemmons DR, Elgin RG, Han VKM, Casella SJ, D’Ercole AJ, Van Wyk JJ 1986 Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulin-like growth factor I. J Clin Invest 77:1548
46. Elgin RG, Busby Jr WH, Clemmons DR 1987 An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84:3254
47. Moses HL, Tucker RF, Leof EB, Coffey Jr RJ, Halper J, Shipley GD 1985 Type beta transforming growth factor is a growth stimulator and a growth inhibitor. In: Feramisco J, Ozanne B, Stiles CD (eds) Cancer Cells. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, vol 3:65-71
48. Van Wyk JJ, Graves DC, Casella SJ, Jacobs S 1985 Evidence from monoclonal antibody studies that insulin stimulates deoxyribonucleic acid synthesis through type I somatomedin receptor. J Clin Endocrinol Metab 61:639
49. Ewton DZ, Falen SL, Florini JR 1987 The type II insulin-like growth factor (IGF) receptor has low affinity for IGF-I analogs: pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor. Endocrinology 120:115
50. Furlanetto RW, DiCarlo JN, Wisehart C 1987 The type II insulinlike growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. J Clin Endocrinol Metab 64:1142
51. Kiess W, Haskell JF, Lee L, Greenstein LA, Miller B, Aarons AL, Rechler MM, Nissley SP 1987 An antibody that blocks insulinlike growth factor (IGF) binding to type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts. J Biol Chem 262:12745
52. Misra P, Hintz RL, Rosenfeld RG 1986 Structural and immunological characterization of insulin-like growth factor II binding to IM-9 cell. J Clin Endocrinol Metab 63:1400